Contact this trialFirst, we need to learn more about you.
Glucagon Receptor Antagonist
GRA (REMD-477) for Type 1 Diabetes
Recruiting0 awardsPhase 2
La Jolla, California
This trial will look at the effects of a new diabetes medication on blood sugar levels, heart health, and ketone production in people with Type 1 diabetes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.